(Q38263140)

1 September 2017

title

Calreticulin mutations in myeloproliferative neoplasms and new methodology for their detection and monitoring (English)

1 reference

1 September 2017

Vicky Nicolaidou

4

0 references

George S Vassiliou

object named as

George Vassiliou

7

0 references

author name string

Jianxiang Chi

1

1 reference

1 September 2017

Menelaos Manoloukos

2

1 reference

1 September 2017

Chryso Pierides

3

1 reference

1 September 2017

Katerina Nicolaou

5

1 reference

1 September 2017

Maria Kleopa

6

1 reference

1 September 2017

Paul Costeas

8

1 reference

1 September 2017

publication date

29 October 2014

1 reference

1 September 2017

1 reference

1 September 2017

volume

94

1 reference

1 September 2017

issue

3

1 reference

1 September 2017

page(s)

399-408

1 reference

Somatic mutations of calreticulin in myeloproliferative neoplasms

1 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00277-014-2232-8

Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-014-2232-8

JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-014-2232-8

Calreticulin gene exon 9 frameshift mutations in patients with thrombocytosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-014-2232-8

The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-014-2232-8

A gain-of-function mutation of JAK2 in myeloproliferative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-014-2232-8

A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-014-2232-8

MPLW515L is a novel somatic activating mutation in myelofibrosis with myeloid metaplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-014-2232-8

Acquired copy-neutral loss of heterozygosity of chromosome 1p as a molecular event associated with marrow fibrosis in MPL-mutated myeloproliferative neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-014-2232-8

Myeloproliferative neoplasms: contemporary diagnosis using histology and genetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-014-2232-8

Another piece of the myeloproliferative neoplasms puzzle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-014-2232-8

Product differentiation by analysis of DNA melting curves during the polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-014-2232-8

Genetics: CALR mutations and a new diagnostic algorithm for MPN.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-014-2232-8

High resolution melting analysis: a rapid and accurate method to detect CALR mutations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-014-2232-8

Comparison of high resolution melting analysis, pyrosequencing, next generation sequencing and immunohistochemistry to conventional Sanger sequencing for the detection of p.V600E and non-p.V600E BRAF mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-014-2232-8

Two novel JAK2 exon 12 mutations in JAK2V617F-negative polycythaemia vera patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-014-2232-8

10.1007/S00277-014-2232-8

21 January 2018

Identifiers

DOI

1 reference

1 September 2017

1 reference